Your browser doesn't support javascript.
loading
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.
Xu, Lihong; Stevens, Janine; Hilton, Mary Beth; Seaman, Steven; Conrads, Thomas P; Veenstra, Timothy D; Logsdon, Daniel; Morris, Holly; Swing, Deborah A; Patel, Nimit L; Kalen, Joseph; Haines, Diana C; Zudaire, Enrique; St Croix, Brad.
Afiliação
  • Xu L; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Stevens J; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Hilton MB; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA. Basic Research Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Seaman S; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • Conrads TP; Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Veenstra TD; Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Logsdon D; Basic Research Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Morris H; Transgenic Core Facility, MCGP, NCI, Frederick, MD 21702, USA.
  • Swing DA; Transgenic Core Facility, MCGP, NCI, Frederick, MD 21702, USA.
  • Patel NL; Small Animal Imaging Program/LASP, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Kalen J; Small Animal Imaging Program/LASP, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Haines DC; Pathology/Histotechnology Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
  • Zudaire E; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA.
  • St Croix B; Tumor Angiogenesis Section, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI) at Frederick, National Institutes of Health, Frederick, MD 21702, USA. stcroix@ncifcrf.gov.
Sci Transl Med ; 6(242): 242ra84, 2014 Jun 25.
Article em En | MEDLINE | ID: mdl-24964992
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores de Ciclo-Oxigenase 2 / Neoplasias Hepáticas / Neoplasias Mamárias Experimentais Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores de Ciclo-Oxigenase 2 / Neoplasias Hepáticas / Neoplasias Mamárias Experimentais Idioma: En Ano de publicação: 2014 Tipo de documento: Article